All Stories

  1. Novel three-dimensional biochip pulmonary sarcoidosis model

    Article • PLoS ONE, February 2021, PLOS

    Dr. Mehdi Mirsaeidi

  2. Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study

    Article • ERJ Open Research, October 2020, European Respiratory Society (ERS)

    Dr. Mehdi Mirsaeidi

  3. Impact of seasonal variation in meteorological conditions on dry eye severity

    Article • Clinical Ophthalmology, November 2018, Dove Medical Press

    Dr. Mehdi Mirsaeidi

  4. A Young Woman with Bradycardia and Hypotension

    Article • Annals of the American Thoracic Society, September 2018, American Thoracic Society

    Dr. Mehdi Mirsaeidi

  5. Regulatory genes in sarcoidosis

    Article • American Journal of Respiratory Cell and Molecular Biology, February 2018, American Thoracic Society

    Dr. Mehdi Mirsaeidi

  6. A risky political game with climate change

    Article • European Respiratory Journal, October 2017, European Respiratory Society (ERS)

    Dr. Mehdi Mirsaeidi

  7. Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2017, Dove Medical Press

    Dr. Mehdi Mirsaeidi

  8. The roles of miRNAs as potential biomarkers in lung diseases

    Article • European Journal of Pharmacology, November 2016, Elsevier

    Dr. Mehdi Mirsaeidi

  9. Management of extrapulmonary sarcoidosis: challenges and solutions

    Article • Therapeutics and Clinical Risk Management, November 2016, Dove Medical Press

    Dr Peter Korsten, Dr. Mehdi Mirsaeidi

  10. Climate change

    Article • Annals of the American Thoracic Society, August 2016, American Thoracic Society

    Dr. Mehdi Mirsaeidi

  11. The simultaneous recording of right- and left-sided electrocardiogram in acute pulmonary embolism

    Article • The American Journal of Emergency Medicine, June 2016, Elsevier

    Dr. Mehdi Mirsaeidi

  12. Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey

    Article • Journal of Global Antimicrobial Resistance, June 2016, Elsevier

    Dr. Mehdi Mirsaeidi

  13. Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis

    Article • Journal of Translational Medicine, April 2016, Springer Science + Business Media

    Dr. Mehdi Mirsaeidi

  14. High prevalence of Mycobacterium tuberculosis mixed infection in the capital of moderate tuberculosis incidence country

    Article • Microbial Pathogenesis, April 2016, Elsevier

    Dr. Mehdi Mirsaeidi

  15. Incidence and predictors of ischemic cerebrovascular stroke among patients on extracorporeal membrane oxygenation support

    Article • Journal of Critical Care, April 2016, Elsevier

    Dr. Mehdi Mirsaeidi

  16. In VitroAntimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran

    Article • Microbial Drug Resistance, March 2016, Mary Ann Liebert Inc

    Dr. Mehdi Mirsaeidi, Dr Saeed B Zaker, Mohammad Hashemzadeh

  17. Pulmonary Mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor?

    Article • Monaldi Archives for Chest Disease, February 2016, PAGEPress Publications

    Dr. Mehdi Mirsaeidi

  18. Reply: Metabolomics and Mycobacterial Disease: Don’t Forget the Bioinformatics

    Article • Annals of the American Thoracic Society, January 2016, American Thoracic Society

    Dr. Mehdi Mirsaeidi

  19. Microbiological Analysis of Hemodialysis Water in a Developing Country

    Article • ASAIO Journal, January 2016, Wolters Kluwer Health

    Dr. Mehdi Mirsaeidi

  20. Duration of ECMO Is an Independent Predictor of Intracranial Hemorrhage Occurring During ECMO Support

    Article • ASAIO Journal, January 2016, Wolters Kluwer Health

    Dr. Mehdi Mirsaeidi

  21. The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis

    Article • International Journal of Hypertension, January 2016, Hindawi Publishing Corporation

    Dr. Mehdi Mirsaeidi

  22. English

    Article • Scientific Reports, December 2015, Nature

    Dr. Mehdi Mirsaeidi, Dr Saeed B Zaker, Mohammad Hashemzadeh

  23. Metabolomics: Applications and Promise in Mycobacterial Disease

    Article • Annals of the American Thoracic Society, September 2015, American Thoracic Society

    Dr. Mehdi Mirsaeidi

  24. Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis

    Article • International Journal of Mycobacteriology, June 2015, Elsevier

    Dr. Mehdi Mirsaeidi

  25. Recurrent Drug-Induced Hepatitis in Tuberculosis—Comparison of Two Drug Regimens

    Article • American Journal of Therapeutics, May 2015, Wolters Kluwer Health

    Dr. Mehdi Mirsaeidi

  26. “Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria

    Article • European Journal of Internal Medicine, May 2015, Elsevier

    Dr. Mehdi Mirsaeidi, Dr Saeed B Zaker, Mohammad Hashemzadeh

  27. Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support

    Article • PLoS ONE, April 2015, PLOS

    Dr. Mehdi Mirsaeidi

  28. Primary sclerosing cholangitis in common variable immune deficiency

    Article • Allergology International, April 2015, Elsevier

    Dr. Mehdi Mirsaeidi

  29. Identification and Genotyping of Mycobacterium tuberculosis Isolated From Water and Soil Samples of a Metropolitan City

    Article • CHEST Journal, April 2015, Elsevier

    Dr. Mehdi Mirsaeidi

  30. Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis

    Article • Journal of Inflammation, March 2015, Springer Science + Business Media

    Dr. Mehdi Mirsaeidi

  31. Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective

    Article • European Respiratory Journal, March 2015, European Respiratory Society (ERS)

    Dr. Mehdi Mirsaeidi

  32. Persistence of Mycobacterium tuberculosis in environmental samples

    Article • International Journal of Mycobacteriology, March 2015, Elsevier

    Dr. Mehdi Mirsaeidi

  33. Nontuberculous mycobacterial disease in North America

    Article • International Journal of Mycobacteriology, March 2015, Elsevier

    Dr. Mehdi Mirsaeidi

  34. Nontuberculous mycobacteria in Middle East: Current situation and future challenges

    Article • International Journal of Mycobacteriology, March 2015, Medknow

    Dr. Mehdi Mirsaeidi

  35. A descriptive analysis of nontuberculous mycobacterial infections (NTM) of the upper extremity

    Article • International Journal of Mycobacteriology, March 2015, Elsevier

    Dr. Mehdi Mirsaeidi

  36. Racial Difference in Sarcoidosis Mortality in the United States

    Article • CHEST Journal, February 2015, Elsevier

    Dr. Mehdi Mirsaeidi

  37. Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Professor Stefano Aliberti, Dr. Mehdi Mirsaeidi

  38. Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr. Mehdi Mirsaeidi

  39. Molecular Epidemiology of Nontuberculous Mycobacteria Isolates from Clinical and Environmental Sources of a Metropolitan City

    Article • PLoS ONE, December 2014, PLOS

    Dr. Mehdi Mirsaeidi

  40. Pneumococcal Vaccine and Patients with Pulmonary Diseases

    Article • The American Journal of Medicine, September 2014, Elsevier

    Professor Stefano Aliberti, Dr. Mehdi Mirsaeidi

  41. Pneumococcal Vaccines: Understanding Centers for Disease Control and Prevention Recommendations

    Article • Annals of the American Thoracic Society, July 2014, American Thoracic Society

    Dr. Mehdi Mirsaeidi

  42. The role of vaccination in preventing pneumococcal disease in adults

    Article • Clinical Microbiology and Infection, May 2014, Elsevier

    Professor Stefano Aliberti, Dr. Mehdi Mirsaeidi

  43. Nontuberculous Mycobacterial Disease Mortality in the United States, 1999–2010: A Population-Based Comparative Study

    Article • PLoS ONE, March 2014, PLOS

    Dr. Mehdi Mirsaeidi

  44. Rituximab in the treatment of refractory pulmonary sarcoidosis

    Article • European Respiratory Journal, January 2014, European Respiratory Society (ERS)

    Dr. Mehdi Mirsaeidi

  45. Highlight on Advances in Nontuberculous Mycobacterial Disease in North America

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Dr. Mehdi Mirsaeidi

  46. Multidrug-resistant tuberculosis treatment with linezolid-containing regimen

    Article • International Journal of Mycobacteriology, December 2013, Elsevier

    Dr. Mehdi Mirsaeidi

  47. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis

    Article • International Journal of Infectious Diseases, November 2013, Elsevier

    Dr. Mehdi Mirsaeidi

  48. Nonsteroidal therapy of sarcoidosis

    Article • Current Opinion in Pulmonary Medicine, September 2013, Wolters Kluwer Health

    Dr. Mehdi Mirsaeidi

  49. Antineutrophil Cytoplasmic Autoantibody–Associated Systemic Vasculitis is Associated With Epstein-Barr Virus in the Setting of HIV Infection

    Article • Infectious Diseases in Clinical Practice, January 2013, Wolters Kluwer Health

    Dr. Mehdi Mirsaeidi

  50. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males

    Article • European Respiratory Journal, July 2012, European Respiratory Society (ERS)

    Dr. Mehdi Mirsaeidi, Dr Jorge Roig

  51. Outcome of Nursing Home Associated Pneumonia in African American Hospitalized Patients

    Article • CHEST Journal, October 2011, Elsevier

    Dr. Mehdi Mirsaeidi

  52. A Comparison of Outcomes of Culture Positive Health-care-Associated and Community-Acquired Pneumonia in African American Population: A Community Hospital Experience

    Article • CHEST Journal, October 2011, Elsevier

    Dr. Mehdi Mirsaeidi

  53. Association Between Time to Clinical Stability and Outcomes After Discharge in Hospitalized Patients With Community-Acquired Pneumonia

    Article • CHEST Journal, August 2011, Elsevier

    Professor Stefano Aliberti, Dr. Mehdi Mirsaeidi

  54. Generalized lymphadenopathy with cystic spleen lesions: a rare presentation of tuberculosis

    Article • International Journal of Infectious Diseases, July 2011, Elsevier

    Dr. Mehdi Mirsaeidi

  55. Utility of gastric lavage for diagnosis of tuberculosis in patients who are unable to expectorate sputum

    Article • Journal of Global Infectious Diseases, January 2011, Medknow

    Dr. Mehdi Mirsaeidi

  56. Thrombocytopenia and Thrombocytosis at Time of Hospitalization Predict Mortality in Patients With Community-Acquired Pneumonia

    Article • CHEST Journal, February 2010, Elsevier

    Dr. Mehdi Mirsaeidi

  57. Vitamin D receptor homozygote mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the Iranian population

    Article • International Journal of Infectious Diseases, January 2010, Elsevier

    Dr. Mehdi Mirsaeidi

  58. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance

    Article • International Journal of Infectious Diseases, September 2009, Elsevier

    Dr. Mehdi Mirsaeidi

  59. The NRAMPI, VDR and TNF-α gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility

    Article • The Brazilian Journal of Infectious Diseases, August 2009, FapUNIFESP (SciELO)

    Dr. Mehdi Mirsaeidi

  60. Predicting Mortality in Patients with Ventilator‐Associated Pneumonia: The APACHE II Score versus the New IBMP‐10 Score

    Article • Clinical Infectious Diseases, July 2009, Oxford University Press (OUP)

    Dr. Mehdi Mirsaeidi

  61. Nontuberculous Mycobacteria Among Patients Who are Suspected for Multidrug-Resistant Tuberculosis—Need for Earlier Identification of Nontuberculosis Mycobacteria

    Article • The American Journal of the Medical Sciences, March 2009, Elsevier

    Dr. Mehdi Mirsaeidi

  62. Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study

    Article • Scandinavian Journal of Infectious Diseases, January 2009, Taylor & Francis

    Dr. Mehdi Mirsaeidi

  63. Incidence, Etiology, Timing, and Risk Factors for Clinical Failure in Hospitalized Patients With Community-Acquired Pneumonia

    Article • CHEST Journal, November 2008, Elsevier

    Professor Stefano Aliberti, Dr. Mehdi Mirsaeidi

  64. The Recent-Transmission of Mycobacterium tuberculosis Strains among Iranian and Afghan Relapse Cases: a DNA-fingerprinting using RFLP and spoligotyping

    Article • BMC Infectious Diseases, August 2008, Springer Science + Business Media

    Dr. Mehdi Mirsaeidi

  65. Acute Myocardial Infarction in Hospitalized Patients with Community‐Acquired Pneumonia

    Article • Clinical Infectious Diseases, July 2008, Oxford University Press (OUP)

    Professor Stefano Aliberti, Dr. Mehdi Mirsaeidi

  66. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran

    Article • Respirology, January 2008, Wiley

    Dr. Mehdi Mirsaeidi

  67. Do mitochondrial DNA haplogroups play a role in susceptibility to tuberculosis?

    Article • Respirology, November 2007, Wiley

    Dr. Mehdi Mirsaeidi

  68. Multi-drug Resistant Tuberculosis in Pregnancy: Need for More Intensive Treatment

    Article • Infection, September 2007, Springer Science + Business Media

    Dr. Mehdi Mirsaeidi

  69. Differences in characteristics between Afghani and Iranian patients with pulmonary tuberculosis

    Article • International Journal of Infectious Diseases, March 2007, Elsevier

    Dr. Mehdi Mirsaeidi

  70. Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients

    Article • Journal of Infection, November 2006, Elsevier

    Dr. Mehdi Mirsaeidi

  71. Chronic Granulomatous Disease with Unusual Clinical Manifestation, Outcome, and Pattern of Inheritance in an Iranian Family

    Article • Journal of Clinical Immunology, May 2006, Springer Science + Business Media

    Dr. Mehdi Mirsaeidi

  72. Lack of association between interferon‐gamma receptor‐1 polymorphism and pulmonary TB in Iranian population sample

    Article • Journal of Infection, May 2006, Elsevier

    Dr. Mehdi Mirsaeidi

  73. The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and Afghan TB cases

    Article • Scandinavian Journal of Infectious Diseases, January 2006, Taylor & Francis

    Dr. Mehdi Mirsaeidi

  74. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran

    Article • International Journal of Infectious Diseases, November 2005, Elsevier

    Dr. Mehdi Mirsaeidi

  75. Inherited disorders of the IL-12-IFN-γ axis in patients with disseminated BCG infection

    Article • European Journal of Pediatrics, August 2005, Springer Science + Business Media

    Dr. Mehdi Mirsaeidi

  76. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations

    Article • Nature Genetics, May 2005, Nature

    Dr. Mehdi Mirsaeidi

  77. Primary multi-drug resistant tuberculosis presented as lymphadenitis in a patient without HIV infection

    Article • Monaldi Archives for Chest Disease, December 2004, PAGEPress Publications

    Dr. Mehdi Mirsaeidi